Med Sci (Paris)
Volume 33, Number 10, Octobre 2017
Nos jeunes pousses ont du talent !
Page(s) 859 - 862
Section Partenariat médecine/sciences - Écoles doctorales - Masters
Published online 10 October 2017
  1. Medler TR, Cotechini T, Coussens LM. Immune response to cancer therapy : mounting an effective antitumor response and mechanisms of resistance. Trends Cancer 2015 ; 1 : 66–75. [CrossRef] [PubMed] [Google Scholar]
  2. Silina K, Rulle U, Kalnina Z. Line A. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures : a novel anti-cancer treatment avenue?. Cancer Immunol Immunother 2014 ; 63 : 643–662. [CrossRef] [PubMed] [Google Scholar]
  3. Zhang Y, Gallastequi N, Rosenblatt JD. Regulatory B cells in anti-tumor immunity. Int Immunol 2015 ; 27 : 521–530. [CrossRef] [PubMed] [Google Scholar]
  4. Lee KE, Spata M, Bayne LJ, et al. Hif1a deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discov 2016 ; 6 : 256–269. [CrossRef] [PubMed] [Google Scholar]
  5. Pylayeva-Gupta Y, Das S, Handler JS, et al. IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discov 2016 ; 6 : 247–255. [CrossRef] [PubMed] [Google Scholar]
  6. Gunderson AJ, Kaneda MM, Tsujikawa T, et al. Bruton tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer. Cancer Discov 2016 ; 6 : 270–285. [CrossRef] [PubMed] [Google Scholar]
  7. Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer 2011 ; 11 : 393–410. [Google Scholar]
  8. Watanabe R, Ishiura N, Nakashima H, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus : CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010 ; 184 : 4801–4809. [CrossRef] [PubMed] [Google Scholar]
  9. Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014 ; 507 : 366–370. [CrossRef] [PubMed] [Google Scholar]
  10. Jin P, Ren H, Sun W, et al. Circulating IL-35 in pancreatic ductal adenocarcinoma patients. Hum Immunol 2014 ; 75 : 29–33. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.